Simulations Plus CEO to Meet Investors at Craig-Hallum Conference
Event summary
- Simulations Plus CEO Shawn O’Connor will participate in the 23rd Annual Craig-Hallum Institutional Investor Conference on May 28, 2026.
- O’Connor will host one-on-one meetings with institutional investors during the event.
- Simulations Plus is a global leader in model-informed and AI-accelerated drug development.
The big picture
Simulations Plus’ participation in the Craig-Hallum conference underscores the growing importance of investor engagement in the biopharma software space. As AI continues to reshape drug development, the company’s ability to articulate its strategic advantages will be crucial. The event provides a platform for Simulations Plus to reinforce its market position and attract institutional investors.
What we're watching
- Investor Sentiment
- How the CEO’s messaging will impact investor confidence in Simulations Plus’ growth trajectory.
- Strategic Positioning
- Whether the company can sustain its leadership in model-informed drug development amid increasing competition.
- Market Dynamics
- The pace at which AI-accelerated drug development adoption will grow in the biopharma sector.